edited by Anthony H. Futerman
Gaucher Disease provides valuable information for academic and industry scientists, and clinicians.
Features:
- Presents not just the most current treatment modalities of this genetic disorder, but the direction of new research in the field
- Touches on all aspects of the disease including biochemical pathology, diagnosis, treatment, patient management, and ethics
- Serves as the only fully comprehensive volume on the disease and the first update on technological advances since 1997
- Contains contributions from world-renowned experts with chapters written by patient organizations, pharmaceutical companies, physicians, public health leaders, and ethicists
Contents
- Gaucher Disease: Molecular Biology and Genotype-Phenotype Correlations
- Cell Biology and Biochemistry of Acid b-Glucosidase:
The Gaucher Disease Enzyme
- Saposin C and Other Sphingolipid Activator Proteins, S. Locatelli Hoops
- The X-Ray Structure of Human Acid-b-Glucosidase:
Implications for Second-Generation Enzyme replacement therapy
- Cellular Pathology in Gaucher Disease
- The Biochemistry and Cellular Biology of Sphingolipids and
Glucosylceramide
- The Development of Enzyme replacement therapy for Lysosomal Diseases: Gaucher Disease and Beyond
- Gaucher Disease Animal Models
- Type 1 Gaucher Disease - Clinical Features
- Neuronopathic Gaucher Disease
- Pathologic Anatomy of Gaucher Disease
- Neuropathological Aspects of Gaucher Disease
- Diagnosis and Laboratory Features
- Imaging in Gaucher Disease, Focused on Bone Pathology
- Radionuclide Evaluation of Gaucher Disease
- Epidemiology and Screening Policy
- Enzyme replacement therapy for Type I Gaucher Disease
- Substrate Reduction Therapy
- Pharmacologic Chaperone Therapy for Lysosomal Diseases
- The Significance of the Blood-Brain Barrier for Gaucher Disease and Other Lysosomal Storage Diseases
- Hematopoietic Stem Cell Transplantation, Stem Cells, and Gene Therapy
- Ethical Concerns in Treating Rare Diseases with Expensive Therapy
- Societal Aspects in Treating Rare Diseases with Expensive Therapy
- Gaucher Disease as a Model for an Orphan Disease: Medical Aspects
- Meeting the Needs of Patients with Gaucher Disease: Pioneering a Sustainable Model for Ultra-Orphan Diseases
- Patients' Perspective
- Societal Perspective: Comment
- Gaucher Associations Around the World
Index